Skip to main content

Table 5 Treatment plan based on conventional vs PSMA PET/CT staging procedure. n = 64 patients

From: Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study

 

Conventional staging

PSMA PET/CT staging

Impact of PSMA PET/CT

Curative

40 (63%)

53 (83%)

Remains curative

38 (59%)

Undecided

15 (23%)

0

Palliative to curative

6 (9%)

Palliative

9 (14%)

11 (17%)

Undecided to curative

9 (14%)

   

Undecided to palliative

6 (9%)

   

Curative to palliative

2 (3%)

   

Remains palliative

3 (5%)